Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
Risk stratification and mitigation in multiple sclerosis.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
[A review of multiple sclerosis (1). Presentation of a case.]
Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in Southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system.
Emerging subspecialties in neurology: neuroimmunology.
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Mutation Update of ARSA and PSAP genes causing Metachromatic Leukodystrophy.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?
Risk evaluation and monitoring in multiple sclerosis therapeutics.
[Biomarkers in multiple sclerosis (a review and experimental data)].
Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
Burden of risk variants correlates with phenotype of multiple sclerosis.
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Linking synaptopathy and gray matter damage in multiple sclerosis.
Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies.
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?
Pages
« first
‹ previous
…
448
449
450
451
452
453
454
455
456
…
next ›
last »